Sparton Medical Systems to Exhibit at the MD&M West

For Immediate Release

SCHAUMBURG, Ill. – February 2, 2010 – Sparton Corporation (NYSE: SPA) today announced that Sparton Medical Systems will be an exhibitor in Booth 1883 at the MD&M West show from February 9-11, 2010 at the Anaheim Convention Center in Anaheim, CA.

Sparton Medical Systems Inc. is an FDA-registered and ISO 13485-certified contract design, development, and manufacturing company specialized in the systems integration of complex laboratory instrumentation and electromechanical point-of-care medical devices for OEMs and emerging medical technology companies within the In Vitro Diagnostics and Therapeutic medical device markets. For more information on Sparton Medical Systems, please visit http://www.spartonmedicalsystems.com/

.

About Sparton Corporation

Sparton Corporation (NYSE:SPA), now in its 110th year, is a provider of complex and sophisticated electromechanical devices with capabilities that include concept development, industrial design, design and manufacturing engineering, production, distribution, and field service to technology-driven companies in the medical device, defense & security systems, and electronic manufacturing services markets. Headquartered in Schaumburg, Ill., Sparton
currently has four manufacturing locations worldwide. The Company's Web site may be accessed at http://www.sparton.com

.

Safe Harbor and Fair Disclosure Statement

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting future results, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission (SEC). The matters discussed in this press release may also involve risks and uncertainties concerning Sparton's services described in Sparton's filings with the SEC. In particular, see the risk factors described in the Company's most recent Form 10K and Form 10Q. Sparton assumes no obligation to update the forward-looking information contained in this press release.

Download PDF →

Analyst Contact

Mark Schlei
Sparton Corporation
Email: mschlei@sparton.com
Office: (847) 762-5812

Media Contact

Mike Osborne
Sparton Corporation
Email: mosborne@sparton.com
Office: (847) 762-5814

Investor Contact

John Nesbett/Jennifer Belodeau
Institutional Marketing Services
Email: jnesbett@institutionalms.com
Office: (203) 972-9200